Guillain-Barré syndrome after COVID-19 vaccination: Report of two cases from Vietnam
| dc.contributor.author | Pham, Dang Hai | |
| dc.contributor.author | Le, Lan Phuong | |
| dc.contributor.author | Nguyen, Hong Tot | |
| dc.contributor.author | Nguyen, Le Phuong Anh | |
| dc.contributor.author | Nguyen, Dinh Tung | |
| dc.contributor.author | Nguyen, Hong Quan | |
| dc.date.accessioned | 2025-03-21T17:46:30Z | |
| dc.date.available | 2025-03-21T17:46:30Z | |
| dc.date.issued | 2022-10-10 | |
| dc.identifier.uri | https://vinspace.edu.vn/handle/VIN/596 | |
| dc.description.abstract | Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020 and since then it has spread to almost every country around the world. Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have been reported. We present two cases of Guillain-Barré Syndrome (GBS) after receiving the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca). Both cases were admitted to the 108 Military Central Hospital, Vietnam, and received plasmapheresis therapy with satisfactory recovery after treatment. | en_US |
| dc.language.iso | en_US | en_US |
| dc.subject | guillain-barré syndrome | en_US |
| dc.subject | gbs | en_US |
| dc.subject | covid-19 vaccination | en_US |
| dc.subject | plasmapheresis | en_US |
| dc.title | Guillain-Barré syndrome after COVID-19 vaccination: Report of two cases from Vietnam | en_US |
| dc.type | Article | en_US |
